Islet oxygen consumption rate dose predicts insulin independence for first clinical islet allotransplants

Transplantation Proceedings

Volumn 46, Issue 6, 2014, Pages 1985-1988

  Kitzmann, J P ^a   O'Gorman, D ^b   Kin, T ^b   Gruessner, A C ^a   Senior, P ^b   Imes, S ^b   Gruessner, R W ^a   Shapiro, A M J ^b   Papas, K K ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ALLOTRANSPLANTATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; GLUCOSE STIMULATED INSULIN RELEASE; GRAFT RECIPIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; OXYGEN CONSUMPTION RATE; PANCREAS ISLET TRANSPLANTATION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 1; METABOLISM; PANCREAS ISLET; PHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; TREATMENT OUTCOME;

COHORT STUDIES; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; OXYGEN CONSUMPTION; PREDICTIVE VALUE OF TESTS; ROC CURVE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84906086431     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2014.06.001     Document Type: Conference Paper

References (24)

1. M.D. Bellin, F.B. Barton, and A. Heitman et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes Am J Transplant 12 2012 1576 1583
2. F.B. Barton, M.R. Rickels, and R. Alejandro et al. Improvement in outcomes of clinical islet transplantation: 1999-2010 Diabetes Care 35 2012 1436 1445
3. A.M. Posselt, G.L. Szot, and L.A. Frassetto et al. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade Transplantation 90 2010 1595 1601
4. N.A. Turgeon, J.G. Avila, and J.A. Cano et al. Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation Am J Transplant 10 2010 2082 2091
5. A.M.J. Shapiro, J.R. Lakey, and E.A. Ryan et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N Engl J Med 343 2000 230 238
6. Collaborative Islet Transplant Registry (CITR) (US) [homepage on the Internet]. Rockville (MD): EMMES Corporation [cited 9 Sep 2013]. Available from: www.citregistry.org.
7. C.K. Colton, K.K. Papas, and A. Pisania et al. Characterization of islet preparations C. Halberstadt, D.F. Emerich, Cellular Transplantation: From Laboratory to Clinic 2007 Academic Press Waltham, MA 85 134
8. K.K. Papas, T.M. Suszynski, and C.K. Colton Islet assessment for transplantation Curr Opin Organ Transplant 14 2009 674 682
9. B. Keymeulen, P. Gillard, and C. Mathieu et al. Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft Proc Natl Acad Sci U S A 103 2006 17444 17449
10. M.D. Bellin, D.E. Sutherland, and G.J. Beilman et al. Similar islet function in islet allotransplant and autotransplant recipients, despite lower islet mass in autotransplants Transplantation 91 2011 367 372
11. D.E. Sutherland, A.C. Gruessner, and A.M. Carlson et al. Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes Transplantation 86 2008 1799 1802
12. A.M.J. Shapiro, C. Ricordi, and B.J. Hering et al. International trial of the Edmonton protocol for islet transplantation N Engl J Med 355 2006 1318 1330
13. K.K. Papas, C.K. Colton, and R.A. Nelson et al. Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice Am J Transplant 7 2007 707 713
14. V. Boyd, O.M. Cholewa, and K.K. Papas Limitations in the use of fluorescein diacetate/propidium iodide (FDA/PI) and cell permeable nucleic acid stains for viability measurements of isolated islets of Langerhans Curr Trends Biotechnol Pharm 2 2008 66 84
15. M.J. Barnett, D. McGhee-Wilson, and A.M.J. Shapiro Variation in human islet viability based on different membrane integrity stains Cell Transplant 13 2004 481 488
16. F. Bertuzzi, and C. Ricordi Prediction of clinical outcome in islet allotransplantation Diabetes Care 30 2007 410 417
17. C.N. Street, J.R. Lakey, and A.M. Shapiro et al. Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome Diabetes 53 2004 3107 3114
18. K.K. Papas, A. Pisania, and H. Wu et al. A stirred microchamber for oxygen consumption rate measurements with pancreatic islets Biotechnol Bioeng 98 2007 1071 1082
19. K.K. Papas, C.K. Colton, and A. Qipo et al. Prediction of marginal mass required for successful islet transplantation J Invest Surg 23 2010 28 34
20. K.K. Papas, M.D. Bellin, and D.E. Sutherland et al. Clinical islet auto-transplant outcome is highly correlated with viable isle dose as measured by oxygen consumption rate CellR4 1 2013 108
21. D. O'Gorman, T. Kin, and S. Imes et al. Comparison of human islet isolation outcomes using a new mammalian tissue-free enzyme versus collagenase NB-1 Transplantation 80 2010 255 259
22. B. Barbaro, P. Salehi, and Y. Wang et al. Improved human pancreatic islet purification with the refined UIC-UB density gradient Transplantation 84 2007 1200
23. C. Ricordi Quantitative and qualitative standards for islet isolation assessment in humans and large mammals Pancreas 6 1991 242 244
24. A. Koh, P. Senior, and A. Salam et al. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success Transplantation 89 2010 465 471